• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别和地域对美国膀胱癌死亡率种族差异的影响。

Gender and geographic influence on the racial disparity in bladder cancer mortality in the US.

作者信息

Underwood Willie, Dunn Rodney L, Williams Candice, Lee Cheryl T

机构信息

Department of Urology, University of Michigan, Ann Arbor, MI 48105, USA.

出版信息

J Am Coll Surg. 2006 Feb;202(2):284-90. doi: 10.1016/j.jamcollsurg.2005.09.009. Epub 2005 Dec 19.

DOI:10.1016/j.jamcollsurg.2005.09.009
PMID:16427554
Abstract

BACKGROUND

In 2005, there were an estimated 63,210 new cases of bladder cancer and 13,180 related deaths in the US. African Americans reportedly have a lower incidence of bladder cancer, but a higher mortality. The objective of this study was to evaluate the gender and geographic differences in bladder cancer survival between Caucasians and African Americans to better understand the racial disparity in bladder cancer survival.

STUDY DESIGN

Surveillance Epidemiology and End Results Program (SEER) data were used to evaluate racial differences in bladder cancer survival from 1973 to 1999. Bivariate and multivariate Cox proportional hazard models were performed to determine the relationship between race and survival, adjusting for cancer stage and grade, marital status, region of country, treatment received, and the interaction between race and region.

RESULTS

African Americans were diagnosed with higher grade (p < 0.001) and higher stage (p < 0.001) tumors, compared with Caucasians. In the multivariable model, African-American race was an independent predictor of poor survival, adjusting for age, marital status, region of the country, stage, grade, treatment received, and interaction between race and region. Surprisingly, African Americans diagnosed in the Atlanta metropolitan area had a substantially worse survival.

CONCLUSIONS

African Americans were diagnosed with more aggressive and more advanced tumors. Adjusted multivariable models demonstrated a survival advantage for Caucasians, with African-American race being an independent predictor of poor survival, especially when diagnosed in the Atlanta metropolitan area. Racial disparity continues to exist in bladder cancer presentation and survival in the US.

摘要

背景

2005年,美国估计有63210例新发膀胱癌病例和13180例相关死亡病例。据报道,非裔美国人膀胱癌发病率较低,但死亡率较高。本研究的目的是评估白种人和非裔美国人在膀胱癌生存方面的性别和地理差异,以更好地了解膀胱癌生存方面的种族差异。

研究设计

利用监测、流行病学和最终结果计划(SEER)的数据评估1973年至1999年膀胱癌生存方面的种族差异。采用双变量和多变量Cox比例风险模型来确定种族与生存之间的关系,并对癌症分期和分级、婚姻状况、国家地区、接受的治疗以及种族与地区之间的相互作用进行调整。

结果

与白种人相比,非裔美国人被诊断出的肿瘤分级更高(p<0.001)、分期更高(p<0.001)。在多变量模型中,非裔美国人种族是生存不良的独立预测因素,对年龄、婚姻状况、国家地区、分期、分级、接受的治疗以及种族与地区之间的相互作用进行了调整。令人惊讶的是,在亚特兰大大都市区被诊断出的非裔美国人生存情况要差得多。

结论

非裔美国人被诊断出患有更具侵袭性和更晚期的肿瘤。调整后的多变量模型显示白种人具有生存优势,非裔美国人种族是生存不良的独立预测因素,尤其是在亚特兰大大都市区被诊断出时。在美国,膀胱癌的表现和生存方面种族差异仍然存在。

相似文献

1
Gender and geographic influence on the racial disparity in bladder cancer mortality in the US.性别和地域对美国膀胱癌死亡率种族差异的影响。
J Am Coll Surg. 2006 Feb;202(2):284-90. doi: 10.1016/j.jamcollsurg.2005.09.009. Epub 2005 Dec 19.
2
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).膀胱癌:生存状况的种族和性别差异(1993 年至 2002 年),分期和分级(1993 年至 2007 年)。
J Urol. 2011 May;185(5):1631-6. doi: 10.1016/j.juro.2010.12.049. Epub 2011 Mar 21.
3
Comparative outcomes of bladder cancer.膀胱癌的比较结果。
Obstet Gynecol. 2006 Jul;108(1):169-75. doi: 10.1097/01.AOG.0000223885.25192.91.
4
The Influence of Race on Overall Survival in Patients with Newly Diagnosed Bladder Cancer.种族对初诊膀胱癌患者总生存的影响。
J Racial Ethn Health Disparities. 2015 Mar;2(1):124-31. doi: 10.1007/s40615-014-0055-x. Epub 2014 Sep 11.
5
Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference.接受根治性膀胱切除术治疗的非裔美国膀胱癌患者的总生存期更差吗?考虑病理分期和种族以外的患者人口统计学因素会产生影响。
Bladder Cancer. 2016 Apr 27;2(2):225-234. doi: 10.3233/BLC-150041.
6
Ethnic differences in bladder cancer survival.膀胱癌生存的种族差异。
Urology. 2011 Sep;78(3):544-9. doi: 10.1016/j.urology.2011.02.042. Epub 2011 Jul 22.
7
Racial disparity in bladder cancer: trends in tumor presentation at diagnosis.膀胱癌的种族差异:诊断时肿瘤表现的趋势
J Urol. 2006 Sep;176(3):927-33; discussion 933-4. doi: 10.1016/j.juro.2006.04.074.
8
Geographic Distribution of Racial Differences in Prostate Cancer Mortality.前列腺癌死亡率的种族差异的地理分布。
JAMA Netw Open. 2020 Mar 2;3(3):e201839. doi: 10.1001/jamanetworkopen.2020.1839.
9
Disappearance of racial disparities in gastrointestinal stromal tumor outcomes.胃肠道间质瘤治疗结果中种族差异的消失。
J Am Coll Surg. 2009 Jul;209(1):7-16. doi: 10.1016/j.jamcollsurg.2009.03.018. Epub 2009 May 28.
10
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period.20 年间,癌症特异性死亡率的种族差异仍未缩小。
Cancer. 2014 May 15;120(10):1532-9. doi: 10.1002/cncr.28617. Epub 2014 Feb 22.

引用本文的文献

1
Socioeconomic disparities in survival of patients with non-muscle invasive urothelial carcinoma.非肌层浸润性尿路上皮癌患者生存的社会经济差异
World J Urol. 2025 Feb 12;43(1):120. doi: 10.1007/s00345-024-05422-2.
2
Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer.非肌层浸润性膀胱癌患者复发风险的预测
Asian J Urol. 2024 Oct;11(4):625-632. doi: 10.1016/j.ajur.2023.04.007. Epub 2024 Feb 23.
3
Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system.
美国退伍军人事务医疗体系中膀胱癌诊断时的种族差异。
BJU Int. 2024 Sep;134(3):473-483. doi: 10.1111/bju.16380. Epub 2024 Apr 29.
4
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes.膀胱癌中的性别二态性:病因、生物学、诊断及预后综述
Front Pharmacol. 2024 Jan 12;14:1326627. doi: 10.3389/fphar.2023.1326627. eCollection 2023.
5
Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers.膀胱癌筛查的分子标志物:对膀胱癌和 FDA 批准的生物标志物的深入了解。
Int J Mol Sci. 2023 Sep 21;24(18):14374. doi: 10.3390/ijms241814374.
6
Racial disparities in conditional survival of patients with bladder cancer: a population-based study.膀胱癌患者条件生存的种族差异:一项基于人群的研究。
BMC Urol. 2023 Jul 18;23(1):122. doi: 10.1186/s12894-023-01293-8.
7
Urinary Bladder Carcinoma in Females: A Clinico-Pathological Assessment.女性膀胱癌:临床病理评估
Cureus. 2023 May 30;15(5):e39753. doi: 10.7759/cureus.39753. eCollection 2023 May.
8
Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer.脂质组学分析鉴定出一种与膀胱癌种族特异性差异相关的新型脂质特征。
Metabolites. 2022 Jun 14;12(6):544. doi: 10.3390/metabo12060544.
9
Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients.分析非肌层浸润性膀胱癌高危型非洲裔美国患者的分子亚型。
Urol Oncol. 2022 Sep;40(9):410.e19-410.e27. doi: 10.1016/j.urolonc.2022.04.013. Epub 2022 May 23.
10
Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement.肌层浸润性膀胱癌患者死亡率种族差异的地理分布:改进的机会。
Cancer Causes Control. 2022 Apr;33(4):613-622. doi: 10.1007/s10552-022-01553-2. Epub 2022 Jan 20.